Table 1.
Energy homeostasis in Mc4r mutant mice
| Mouse line | Body weight | Energy intake | Energy expenditure | Glucose homeostasis | Autonomic outflow | Other phenotypes | Ref. |
|---|---|---|---|---|---|---|---|
|
Mc4r−/− Mixed background |
Increased body weight from 5 weeks | Hyperphagic. 46% increase in average daily consumption | NR | Hyperglycemic and hyperinsulinemic (more pronounced in males) | NR | Increased axial length. Normal serum corticosterone levels. |
16 |
|
Mc4r−/− Mixed background |
Pair-fed male mice show normal body weight. Pair-fed female mice show intermediate body weight. |
Non-pair-fed mice hyperphagic at 14 weeks of age (not at 10 weeks) | Reduced basal VO2 consumption at 7 weeks (precedes obesity). Non-pair-fed males hypolocomotive during dark cycle. Normal basal body temperature and response to cold exposure |
Non-pair-fed mice hyperglycemic and hyperinsulinemic. Pair-fed mice normal glucose and insulin levels |
Insensitive to leptin-mediated BAT Ucp1 induction | NR | 48 |
|
Mc4r−/− Congenic BL/6 (3–5 generations) |
Increased body weight. Exaggerated weight gain on HCD. |
Hyperphagic. Normal body weight response to caloric restriction. Normal feeding response to overnight fasting. Increased consumption on high-fat diet. |
Reduced basal VO2 consumption. Reduced exergonic response to HCD. Increased respiratory exchange ratio on HCD. Normal basal body temperature and response to cold exposure. |
Pre-obese mice are normoglycemic and normoinsulinemic. Obese mice show hepatic insulin resistance. |
Reduced exergonic response to HCD not due to reduced SNS outflow to BAT | Normal body weight and feeding response to cold exposure. Reduced circulating triglycerides. Increased hepatic fatty acid synthesis. |
47, 81, 91 |
|
Mc4r−/− Mixed background |
Increased body weight from 5 weeks | Hyperphagic from weaning | Pre-obese mice exhibit increased metabolic rate | NR | NR | NR | 134 |
|
Mc4r−/− Mixed background |
NR | NR | NR | NR | NR | Increased circulating high- density lipoprotein | 93 |
|
Mc4r−/− Mixed obesity- resistant background |
Increased body weight and adiposity from 5 weeks | Hyperphagic. Pre-obese mice responsive to anorectic effect of leptin. |
NR | NR | Insensitive to leptin-mediated BAT Ucp1 induction | NR | 135 |
|
Mc4r−/− Mixed background |
Increased body weight from 5 weeks | Insensitive to anorectic effects of MTII | Insensitive to exergonic effects of MTII. Hypolocomotive during the dark cycle. |
NR | NR | NR | 136 |
|
Mc4r−/− Mixed background |
NR | Insensitive to anorectic effects of MTII. Pre-obese mice responsive to anorectic effect of leptin. Obese mice unresponsive to anorectic effect of leptin. Mice sensitive to orexigenic effects of NPY. |
NR | NR | NR | NR | 137 |
|
Mc4r−/− Mixed background (females) |
NR | Insensitive to anorectic effects of CCK | NR | NR | NR | NR | 138 |
|
Mc4r−/− Mixed background |
NR | Higher breakpoint in a progressive-ratio lever-pressing assay | NR | NR | NR | NR | 50 |
|
Mc4r−/− Mixed background |
NR | NR | NR | NR | NR | No antisecretory response from VIP- stimulated intestinal L-cells. Reduced PYY release. | 55 |
|
Mc4r−/− Congenic BL/6 |
Increased body weight from 7 weeks and increased adiposity | Hyperphagic | NR | Hyperglycemic. Hyperinsulinemic. |
NR | Obese mice normotensive, bradycardic, normal hemodynamic response to high salt diet. Obese and pair-fed mice insensitive to hypertensive effects of leptin. |
86, 139 |
|
Mc4rloxTB/loxTB Mixed background |
Increased body weight from 4 weeks | Hyperphagic. Insensitive to anorectic effects of MTII. |
Reduced VO2 consumption | Hyperglycemic and hyperinsulinemic from 5 weeks of age | Normotensive | Increased axial length | 53, 82 |
| Mc4rloxTB/loxTB | NR | NR | NR | Exaggerated fasting glucose levels and glucose intolerance during the dark cycle. Constant light conditions improves glycemia. | NR | NR | 140 |
|
Mc4rloxTB/loxTB Congenic 129 and mixed background |
Increased body weight from 7 weeks | NR | NR | NR | NR | Reduced sensitivity to Roux-en-Y gastric bypass | 56 |
|
Zp3-Cre:: Mc4rloxTB/loxTB Mixed background |
Normal body weight | NR | NR | NR | NR | NR | 53 |
|
Nestin-Cre:: Mc4rloxTB/loxTB Mixed background |
Normal body weight | NR | NR | NR | NR | Normalized axial length | 53 |
|
Sim1-Cre:: Mc4rloxTB/loxTB Mixed background |
60% reduction in body weight and reduced fat and lean mass | Normalized food intake. Re-sensitized to anorectic effect of MTII | Reduced VO2 consumption. Hypometabolism precedes hyperphagia. Insensitive to exergonic effects of MTII. |
Mildly improved serum glucose and insulin levels at 5 weeks. Normalized glucose levels and at improved insulin levels 12 weeks | Normotensive | Normalized axial length | 53, 67, 82 |
| Chat-ires-Cre:: Mc4rloxTB/loxTB | 10% reduction in body weight and reduced fat mass | Hyperphagic | Normalized VO2 consumption | Mildly improved serum glucose and insulin levels. Insulin resistant. | Hypertensive during dark cycle | Increased axial length | 69, 82 |
| Phox2b-Cre:: Mc4rloxTB/loxTB | No improvement in body weight or fat mass | Hyperphagic | No improvement in VO2 consumption | No improvement in serum glucose levels. Normoinsulinemic and not insulin resistant | NR | Increased axial length | 69 |
| Sim1-Cre:: Mc4rloxTB/loxTB:: vGlut2loxP/loxP | No improvement in body weight or fat mass | Hyperphagic | No improvement in VO2 consumption. Insensitive to exergonic effects of MTII | NR | NR | NR | 67 |
| vGlut2-ires-Cre:: Mc4rloxTB/loxTB | Normalized body weight | Normalized food intake | Normalized VO2 consumption | Normalized serum glucose and insulin levels | Normalized axial length | 54 | |
| vGat-ires-Cre:: Mc4rloxTB/loxTB | No improvement in body weight | NR | NR | NR | NR | NR | 54 |
| Oxt-ires-Cre:: Mc4rloxTB/loxTB | No improvement in body weight | NR | NR | NR | NR | NR | 54 |
| Crh-ires-Cre:: Mc4rloxTB/loxTB | No improvement in body weight | NR | NR | NR | NR | NR | 54 |
| Pdyn-ires-Cre:: Mc4rloxTB/loxTB | No improvement in body weight | NR | NR | NR | NR | NR | 54 |
| Avp-ires-Cre:: Mc4rloxTB/loxTB | No improvement in body weight | NR | NR | NR | NR | NR | 54 |
| Drd1-cre:: Mc4rloxTB/loxTB | Mild improvement in body weight and fat mass | Mild improvement in hyperphagia on chow. Reduction in meal size. Partial restoration of MTII sensitivity. | No improvement in VO2 consumption | NR | NR | NR | 49 |
| Mc4rloxP/loxP | Normal body weight | NR | NR | NR | NR | NR | 54 |
| EIIa-Cre:: Mc4rloxP/loxP | Increased body weight from 5 weeks. Increased fat and lean mass. | Hyperphagic | NR | NR | NR | Increased axial length | 54 |
| Sim1-Cre:: Mc4rloxP/loxP | Increased body weight from 6 weeks. Increased fat mass. | Hyperphagic | NR | NR | NR | Increased axial length | 54 |
| Chat-ires-Cre:: Mc4rloxP/loxP | Increased body weight from 8 weeks. 40% increase by 20 weeks. Increased fat and lean mass. Increased sensitivity to HCD. | Normal feeding behavior. Hyperphagic on HCD. Reduced Ucp1 induction on HCD. | Reduced energy expenditure, intermediate to Mc4rΔ/Δ. Reduced diet-induced hypermetabolism. Normal body temperature |
Hyperglycemia and hyperglucagonemia comparable to Mc4rΔ/Δ. Intermed iate hyperinsulinemia. Insulin resistant. | Reduced thermogenic response to cold exposure. Reduced Ucp1 induction on cold exposure or high-calorie diet. | Normal axial length | 70 |
| Phox2b-Cre:: Mc4rloxP/loxP | No effect on body weight or composition. Normal sensitivity to HCD. | Normal feeding behavior on HCD | Normal exergonic response to a HCD | Normoglycemic and normoglucagonemic. Hyperinsulinemic. | Normal Ucp1 induction | NR | 70 |
Phenotypes arising from the germline and conditional genetic manipulations of mouse Mc4r expression. NR, not reported; CCK, cholecystokinin; HCD, high calorie diet.